Allistair Booth
Partner
Allistair is one of the lead partners in our Tier 1 ranked Life sciences & health transactional team.
Allistair's experience
-
Successfully acted for Evgen Pharma Plc, a clinical stage drug development company developing sulforaphane based medicines for the treatment of multiple diseases, who have completed a $160 million licensing deal for the global rights of lead asset, SFX-01, in neurodevelopmental disorders and schizophrenia to Stalicla SA.
- $160m
- United Kingdom and Switzerland
- Technology, Science & Industry
-
Advised the UK government on its contracts for the purchase of significant volumes of two novel, Covid-19 specific, antivirals. The two antivirals have been developed by MSD and Pfizer. MSD’s antiviral - Molnupiravir - has been shown to cut hospitalisation rates of Covid-19 patients by nearly half.
- United Kingdom
- Intellectual Property
-
Advised the UK government on an agreement to purchase an additional 60m doses of the Pfizer BioNTech Covid-19 vaccine for the autumn revaccination programme.
- United Kingdom
- Technology, Science & Industry
-
Advised English biotech company OXGENE (Oxford Genetics and its shareholders including Mercia Asset Management, Invesco and Canaccord) on the sale of OXGENE to WuXi for an undisclosed sum. OXGENE was founded in 2011 and specialises in the discovery and biomanufacture of cell and gene therapy technologies.
- United Kingdom
- Technology, Science & Industry
-
Advised AIM-listed Evgen Pharma plc, a clinical stage drug development company, on a placing and open offer, to raise £11 million.
- £11,000,000
- United Kingdom
- Technology, Science & Industry
-
Advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo). The transaction transfers ownership of the brand portfolio, comprised of Flux®, Decubal®, Lactocare®, Apobase®, Dailycare® and Fludent® from Teva to Karo. The acquisition is a pure asset deal.
- €84m
- Cross-border
- Retail & Consumer
-
Advised Paion AG, a specialty pharma company, on their exclusive licensing agreement with La Jolla Pharmaceutical for commercialisation of Giapreze™ (Angiotensin II) and Xerava ™ (Eravacycline) in the EEA, the UK and Switzerland.
- Cross-border
- Technology, Science & Industry
-
Advised Imcyse, a clinical stage biotech company, on its licensing deal with Pfizer Inc for the use of some of Imcyse’s novel Imotopes in the field of rheumatoid arthritis. Potential milestones payments to Imcyse are under the agreement to total $180m.
- $180m
- Cross-border
- Technology, Science & Industry
-
Advised the UK government on its agreement with Pfizer and BioNTech for the supply of a vaccine against COVID-19. The Pfizer BioNTech vaccine was the first approved for use in the world and is seen as a key weapon in the fight against Covid
- United Kingdom
- Government and public sector
-
Advising Evgen on the licensing of its sulforaphane stabilisation technology in a number of non-pharmaceutical applications to Juvenescence Ltd. In particular, Juvenescence intends to market and sell a high-end nutritional health product containing a defined dose of sulforaphane extracted from natural sources. Under the terms of the license agreement, Evgen will receive milestone and option payments of up to $10.5m and also receive royalties on future product sales.
- United States
- Technology & Digital Markets
Credentials
-
2013Joined Pinsent Masons
-
1997Fasken Martineau LLP (formerly Stringer Saul LLP), Partner
-
1992Qualified - England and Wales
-
1988Qualified - New Zealand
-
1988University of Auckland – LLB & Bcomm
Out-Law / Insight by Allistair Booth
People who viewed Allistair Booth also viewed
Show me all
Walter Clark
Partner
Walter is a corporate M&A lawyer, with a primary focus on deals in the financial services sector across the UK, particularly for clients with a strong presence in Scotland.
Hannah Griffiths
Partner
Hannah is a restructuring and insolvency lawyer with extensive commercial litigation expertise. She provides strategic structuring, restructuring, recapitalisation, insolvency, equity and trusts, and general corporate dispute advice to insolvency practitioners, directors, funders and boards of corporations of all sizes.
Hinesh Shah
Partner, Forensic Accountant
Hinesh is a forensic accountant and specialises in leading investigations on fraud, financial crime and accounting matters with extensive experience of working with clients in the financial services, infrastructure and energy sectors.
Hayley Goldstone
Partner, Head of Pensions Litigation
Hayley specialises in pensions litigation and co-ordinates the firm’s pensions litigation practice outside London.